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The budding yeast Saccharomyces cerevisiae RAS genes (RAS1
and RAS2) encode small monomeric guanine nucleotide-binding
proteins that demonstrate their biological functions through a
cycle of GDP/GTP exchange and GTP hydrolysis [1]. RAS genes
are highly conserved among eukaryotes. Mammalian cells have
at least three distinct Ras proteins, Ha-Ras, N-Ras, and Ki-Ras
[2], all of which can act as oncogenes when activated by certain
mutations. Ras proteins play a centrol role in regulating the
cAMP-PKA pathway, which plays an important role in the con-
trol of many cellular processes, including nutrient sensing, regu-
lation of cell proliferation, carbon storage and stress resistance
[3]. They localize to the cytoplasmic face of the plasma mem-
brane to regulate numerous cellular processes by interacting
with a variety of cellular effectors. Ras proteins are negatively
regulated by GTPase activating proteins, Ira1p and Ira2p [4],
and positively regulated by Ras-GEFs (Guanine nucleotide Ex-
change Factors), Cdc25p and Sdc25p, that catalyze the transfor-
mation from inactive GDP-bound form to active GTP-bound
form. CDC25 gene product is a 180 kDa membrane bound protein
that constitutes the principal Ras-GEF in Saccharomyces cerevisiaechemical Societies. Published by E[5–7], whereas SDS25 gene is considered dispensable and is nor-
mally expressed only during nutrient depletion or on non-fer-
mentable carbon source [8]. The activated Ras proteins
stimulates adenylate cyclase (encoded by CYR1), which catalyses
synthesis of the second messenger cAMP [9]. Intracellular cAMP
is hydrolyzed by low-afﬁnity (Pde1p) and high afﬁnity (Pde2p)
phosphodiesterases [10,11]. Increased cAMP activates PKA by
binding to its regulatory subunit (encoded by BCY1) and release
of the active catalytic subunits (encoded by three genes TPK1,
TPK2 and TPK3) [12,13], that phosphorylate a variety of proteins.
It is known that addition of glucose to yeast cells grown on non-
fermentable carbon source results in a rapid transient rise in intra-
cellular cAMP level, which is under a rigorous feedback inhibition
by PKA [14]. Mutants with attenuated PKA activity display hyper-
accumulation of cAMP, whereas hyperactive PKA display reduced
cAMP level. The feedback regulation of cAMP accumulation by
PKA can occur at the level of its degradation and synthesis through
Pde proteins [15,16], Ras proteins [17,18], Ira proteins [19,20] and
Cdc25p [21,22].
This work studies the PKA-regulated Ras2p localization and
Ras2-GTP level. We show that activated PKA causes Ras2p relocal-
ization from membrane to cytoplasm, and that PKA down-regu-
lates Ras2p activity through the reduced association between
Ras2-GTP and Cdc25p. These data reveal the involvement of Ras2p
localization and Ras2-GEF Cdc25p in the feedback inhibition of
Ras2p by PKA.lsevier B.V. All rights reserved.
Table 2
List of Saccharomyces cerevisiae strains used in this study.
Strain Genotype Source
W303-
1A
MATa leu2 ura3 trp1 his3 ade2 can1 Thomas
(1989)
W303-
1B
MATa leu2 ura3 trp1 his3 ade2 can1 Thomas
(1989)
DJ311 W303-1A yak1D bcy1D tpk1D tpk2D tpk3D Jian Dong
(2010)
DJ401 W303-1A CDC25-3HA Jian Dong
(2010)
DJ402 W303-1A yak1D tpk1D tpk2D tpk3D CDC25-
3HA
Jian Dong
(2010)
DJ424 W303-1A yak1D bcy1D tpk1D tpk2D tpk3D
CDC25-3HA
Jian Dong
(2010)
ZHS304 W303-1A bcy1D tpk2D tpk3D CDC25-3HA Jian Dong
(2010)
ZHS301 W303-1A bcy1D tpk3D CDC25-3HA Jian Dong
(2010)
ZHS804 W303-1A RAS2val19 CDC25-3HA Jian Dong
(2010)
PMA203 W303-1A RAS2val19 Yun Hu (2009)
DJ296 DJ311W303-1B This work
DJ301 W303-1A yak1D tpk1D tpk2D tpk3D This work
DJ296-2 W303-1A bcy1D tpk1D tpk2D This work
DJ296-3 W303-1A bcy1D tpk2D tpk3D This work
DJ296-4 W303-1A bcy1D tpk1D tpk3D This work
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2.1. Plasmids and strains
The plasmid vector YCplac22 [23] was used for construction of
plasmids YCpGFPRAS2 and YCpGFPRAS2val19. Primers used for
plasmid construction are listed in Table 1. Plasmid YCpGFPRAS2
was constructed through three steps: the sequence encoding the
RAS2 promoter from 895 bp (ATG start codon = +1) of 50 non-
coding sequence to 1 bp was ampliﬁed from wild-type yeast
genomic DNA using primer pair YCpGR-1 (containing the nucleo-
tide sequence 895 to 876 of the RAS2 gene) and YCpGR-2 (con-
taining the restriction site for Bam HI and nucleotide sequence18
to 1 of the RAS2 gene). The PCR product was inserted into the
same Xba I-Bam HI digested plasmid YCplac22, creating the plas-
mid YCpGRA; The sequence of the GFP (Green Fluorescent Protein)
coding sequence from +1 bp (ATG start codon = +1) of 50 non-cod-
ing sequence to +714 bp was ampliﬁed using primer pair YCpGR-3
(containing the restriction site for Bam HI and nucleotide sequence
+1 to +24 of the GFP gene) and YCpGR-4 (containing the restriction
site for Bam HI and nucleotide sequence +689 to +714 of the GFP
gene). The PCR product was inserted into the same Bam HI di-
gested plasmid YCpGRA and verifying using PCR ampliﬁcation, cre-
ating the plasmid YCpGRB; The sequence of the RAS2 coding
sequence and terminator from +4 bp (ATG start codon = +1) of 50
non-coding sequence to +2139 bp was ampliﬁed from wild-type
yeast genomic DNA using primer pair YCpGR-5 (containing the
restriction site for Bam HI and nucleotide sequence +4 to +22 of
the RAS2 gene) and YCpGR-6 (containing the nucleotide sequence
+2119 to +2139 of the RAS2 gene). The PCR product was inserted
into the Bam HI-EcoR I double digested plasmid YCpGRB, creating
the plasmid YCpGFPRAS2. Plasmid YCpGFPRAS2val19 was con-
structed by inserting the RAS2val19 coding sequence and terminator
from +4 bp to +2139 bp (ampliﬁed from strain PMA203 genome
using primer pair YCpGR-5 and YCpGR-6) into the Bam HI-EcoR I
double digested plasmid YCpGRB. Plasmid pGEX-TPK1 was con-
structed as follows: The TPK1 sequence from +4 bp (ATG start co-
don = + 1) of 50 non-coding sequence to +1923 bp was ampliﬁed
from yeast genomic DNA using primer pair pGEXTPK1U (contain-
ing the restriction site for BamH I and nucleotide sequence +4 to
+23 of the TPK1 gene) and pGEXTPK1D (containing the restriction
site for Not I and nucleotide sequence +1175 to +1194 of the
TPK1 gene). The PCR product was BamH I-Not I double digested
and inserted into the same BamH I-Not I digested plasmid
pGEX4T-1, creating the plasmid pGEX-TPK1.
Yeast strains used in this study are listed in Table 2. Diploid of
yak1D bcy1D tpk1D tpk2D tpk3D (DJ296) was obtained by mating
reaction of DJ311 and W303-1B. Constitutively PKA-deleted
(DJ301) and -activated mutants (DJ296-2, DJ296-3 and DJ296-4)
were obtained by tetrad analysis from DJ296 and veriﬁed using
PCR.Table 1
List of primers used in this study.
Primer name Sequence (50-30)
YCpGR-1 CGCAGACTGTGAGCTAGAAT
YCpGR-2 GGGCCGGATCCCATTTTTTTTTCTGTATA
YCpGR-3 GGGCCCGGATCCATGTCTAAAGGTGAAGAATTATTC
YCpGR-4 GGGCCCGGATCCTTTGTACAATTCATCCATACCATG
YCpGR-5 GGGCCCGGATCCCCTTTGAACAAGTCGAACA
YCpGR-6 TTGAATTTCATTTCGTGTGAT
pGEXTPK1U GGGCCCGGATCCTCGACTGAAGAACAAAATGG
pGEXTPK1D GGGCCCGCGGCCGCTTAGAAGTCCCGGAAAAGAT
Relevant restriction sites are underlined.2.2. Media, growth conditions and yeast methods
Yeast cells were grown in YP (1% yeast extract, 2% peptone)
medium supplemented with 2% glucose. Cells carrying plasmids
were grown in synthetic complete (SC) medium supplemented
with adenine, uracil, and amino acids as appropriate but lacking
essential components to maintain plasmids. To express GST-RBD
fusion proteins, plasmids pGEX2T-RBD (obtained by Colombo S)
were transformed to Escherichia coli strain BL21, which was subse-
quently cultured in Luria-Bertani medium with ampicillin resis-
tance. Diploid yeast cells were sporulated on 0.1% KAc medium
at 28 C for 2 days. Yeast transformations were performed by the
lithium acetate method. Thermal tolerance analysis of yeast cells
was performed by incubating cells in liquid SC glucose medium
at 30 C an A600nm of 1. A series of dilutions of treated and un-
treated cells were spotted on SC glucose plate, incubated for 2 days
at 30 C.
2.3. Microscopy
Cells were incubated in SC medium supplemented with 2% glu-
cose or 3% glycerol (to an A600nm of 1) and collected by centrifuga-
tion. Microscopic analysis was performed using an Olympus BX51
microscope with a 100 UplanApo objective and appropriate ﬁlter
cubes. Cells were visualized by differential interference contrast
(DIC) or ﬂuorescence microscopy. Images were captured with a
SPOT CCD (Diagnostic instruments Inc.) camera and, where appro-
priate, Adobe Photoshop was used to optimize image contrast.
This experiment was done at least in triplicate, representative re-
sults are presented.
2.4. Ras2-GTP/RBD pull-down and Cdc25p–Ras2-GTP/RBD co-pull-
down assay
The sensitive Ras2-GTP/RBD pull-down and Cdc25p–Ras2-GTP/
RBD co-pull-down assay was performed as described by Colombo S
[18] with some modiﬁcations. Mutant strains tagged with a 110 bp
fragment containing three HA-epitope repeats were used so that
the Cdc25p could be detected using anti-HA antibody. Cells were
grown in YP medium supplemented with 2% glucose to an A600nm
of 1, collected by centrifugation, washed with ice-cold water twice
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50 mM Tris–HCl, pH 7.5, 150 mM NaCl, 1 mM EDTA, 5 mM MgCl2
and 0.1% NP-40. Cells were broken by gently vortex with glass
beads in ice-cold cell lysis buffer added with 0.25% sodium deoxy-
cholate, 1 mM PMSF, 10 mM NaF, 1 mM sodium orthovanadate,
10 mM b-glycerol phosphate, and one tablet of Protease Inhibitor
Mixture (Roche) in 50 ml of extraction medium. The mixture was
then centrifuged at 13 000 rpm for 5 min at 4 C to remove unbro-
ken cells and glass beads. The supernatant is referred as cell lysate.
Protein concentrations were determined by RC DC protein assay
(BIO RAD). Cell lysate (150 lg) diluted in 200 ll of volume was
incubated with 20 ll bed volume of glutathione S-transferase
(GST)-RBD fusion protein pre-bound to glutathione-sepharose
(GE) for 1 h at 4 C. Bound proteins were diluted in 2 sample buf-
fer, incubated for 5 min at 65 C, loaded onto PAGE–SDS gel, sepa-
rated, and transferred onto nitrocellulose membranes. Ras2-GTP
was detected by anti-Ras2 antibody (Santa Cruz) and Cdc25p
bound to Ras-GTP by anti-HA antibody (Santa Cruz). Total Ras2p
was detected in equal quantity of cleared cell lysate using the same
anti-Ras2 antibody. The Ras2-GTP/total Ras2 and Ras2-GTP/
Cdc25p ratios were determined by densitometric analysis. Band
intensities were quantiﬁed using SCION IMAGE software (version
4.03, Scion Co.). Data shown in the graphs were the average of
three independent experiments and error bars are reported.Fig. 1. Effect of PKA activity on Ras2p localization. (A) Ras2p relocalization upon gluco
plasmid YCpGFPRAS2 were grown in glycerol-based synthetic medium to log phase. Ras2
PKA mutants. Mutant cells transformed with plasmid YCpGFPRAS2 were grown in gluco2.5. In vitro protein kinase assay
Tpk1-GST fusion protein was expressed in E. coli strain BL21
transformed with plasmid pGEX-TPK1, expression and puriﬁcation
of Tpk1p was performed similar as Ras2p expression and puriﬁca-
tion [22]. Twenty microliter bed volume of protein complex was
precleaned using Protein Kinase Buffer (50 mM Tris–HCl, pH 7.5,
10 mM MgCl2, 1 mM dithiothreitol, 1 mM EGTA, 0.25% sodium
deoxycholate, 1 mM PMSF, 10 mM NaF, 1 mM sodium orthovana-
date, 10 mM b-glycerol phosphate) and then added with 50 ll Pro-
tein Kinase Buffer plus 2 ll puriﬁed Tpk1 protein. The
phosphorylation reaction was started by addition of 20 mM ATP,
incubated for 30 min at 30 C and ﬁnally terminated by adding
2 sample buffer. The samples were incubated for 5 min at 65 C
and subjected to western blot analysis. Quantitative analysis re-
sults shown in the graphs were the average of three independent
experiments and error bars are reported.
3. Results
3.1. High PKA activity leads to a cytoplasm dispersion of Ras2p
To detect the Ras2p localization in living cells, we transformed
yeast cells with plasmid YCpGFPRAS2 that carries GFP-RAS2 allele.se addition to glucose-starved cells. Wild-type cells (W303-1A) transformed with
-GFP was observed before and after addition of 2% glucose. (B) Ras2p localization in
se-based synthetic medium to log phase.
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control of the RAS2 promoter, was found to be functional, as it
can complement the lethality associated with ras2D mutant cells
on glycerol (data not shown). As wild-type cells (W303-1A) carry-
ing plasmid YCpGFPRAS2 were grown on SC medium supple-
mented with 3% glycerol to an A600nm of 1, glucose was added to
a ﬁnal concentration of 2% (w/v). As shown in Fig. 1A, Ras2p was
found to be predominantly membrane localized on glycerol, how-
ever following addition of glucose it was in a large part relocalized
to the cytoplasm. As the glucose-induced cAMP signals and acti-
vated PKA, to gain further evidence for the role of PKA in regulating
Ras2p localization, we constructed PKA-deleted mutant (DJ301)
that lacks all three genes for catalytic subunits of PKA (TPK1,
TPK2 and TPK3) and Yak1p kinase to suppress the lethal phenotype
[24] as well as PKA-activated mutants (DJ296-2, DJ296-3 and
DJ296-4) that lack the regulatory subunit gene (BCY1) and two cat-
alytic subunit genes. The PKA mutants were incubated on glucose
to an A600nm of 1. Fig. 1B shows that Ras2p was sharply membrane
localized in PKA-deleted cells (DJ301), whereas a signiﬁcant cyto-
plasmic localization of Ras2p was observed in DJ296-2, DJ296-3
and DJ296-4 mutants. These results suggest that Ras2p localization
is monitored by PKA, and that any catalytic subunit of PKA is suf-
ﬁcient for the protein cytoplasmic localization.
3.2. The intracellular level of Ras2-GTP is down-regulated by PKA
activity
Ras2p has been suggested to be a possible target of the feedback
inhibition in the Ras-cAMP pathway, as in PKA-attenuated cells
Ras2p displays elevated basal and induced Ras2-GTP level [18].
To further verify the down-regulation of Ras2p activity by PKA,
we adopted the Ras2-GTP/RBD pull-down assay to examine the
intracellular Ras2-GTP level in PKA mutants. Cells were incubatedFig. 2. Effect of PKA activity on the intracellular level of Ras2-GTP. PKA mutant cells we
down assay. Protein samples were separated on 12.5% PAGE–SDS gels. (A) Intracellular
activated cells.on glucose medium to an A600nm of 1. As shown in Fig. 2A, the
intracellular level of Ras2-GTP is elevated in PKA-deleted cells
(DJ301), whereas it is remarkably diminished in PKA-activated
cells (DJ296-3). Though its high PKA activity, mutant carrying
RAS2val19 allele (PMA203) exhibits an astonishingly high level of
Ras2-GTP due to its impaired GTPase activity [25]. The different
levels of Ras2-GTP in three mutants of elevated and constitutive
PKA (DJ296-2, DJ296-3 and DJ296-4) might be due to the different
activity of the three catalytic subunits (Fig. 2B). Above all, these
data reveal a down-regulation of intracellular level of Ras2-GTP
by PKA activity.
3.3. The intracellular localization of Ras2p is not affected by its
activation state
The above PKA-regulated Ras2p localization and Ras2-GTP level
led us to suspect that the intracellular Ras2-GTP binding capacity
might be involved in regulating Ras2p localization. Therefore, we
tentatively investigated the localizations of the wild-type Ras2p
and dominant and overactive Ras2val19 protein in PKA mutants.
As shown in Fig. 3A and B, both proteins display indistinguishable
localizations in PKA mutants (display membrane localization in
DJ301 cells and cytoplasmic localization in DJ296-3 cells). As the
thermal tolerance of yeast stain was proportional to PKA activity
in a reversed manner [26], PKA mutants carrying RAS2val19 plasmid
were also subjected to heat shock for 3 min at 52 C in a water bath
to further verify their PKA activities (Fig. 3C). Though expressing
the dominant and overactive Ras2val19, mutants of DJ301 and
DJ296 still exhibit their intrinsic PKA activity, implicating that
Ras2p localization is inﬂuenced by PKA rather than the protein
activity. However, the wild-type strain (W303-1A) carrying RAS2-
val19 plasmid exhibits an activated PKA and a distinct cytoplasmic
localization of Ras2val19 protein (Fig. 3B and C). This phenomenonre incubated on glucose medium to log phase and subjected to Ras2-GTP/RBD pull-
level of Ras2-GTP in PKA-mutant cells. (B) Intracellular level of Ras2-GTP in PKA-
Fig. 3. Effect of Ras2p activation state and PKA activity on Ras2p localization. Wild-type (W303-1A) and PKA-mutant cells (DJ301 and DJ296-3) were transformed with either
RAS2 or RAS 2val19 plasmid and grown in glucose-based synthetic medium to log phase. (A) Ras2p localization. (B) Ras2val19 protein localization. (C) Heat treated and untreated
cells transformed with RAS2 or RAS2val19 plasmid were serially diluted with a factor of 10, respectively.
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Ras2val19, which stimulates the synthesis of cAMP and conse-
quently activates PKA, leading to a cytoplasmic localization of
Ras2val19 protein. These data further prove that Ras2p localization
is regulated by PKA activity rather than the protein activation state.
3.4. The intracellular protein association between Cdc25p and Ras2-
GTP is down-regulated by PKA activity
As the regulation of Ras2-GEF Cdc25p phosphorylation degree
and in vitro Ras2-GEF activity of Cdc25p by PKA [22], we tenta-
tively studied the involvement of Cdc25p in the down-regulation
of Ras2p by PKA through the protein association between Cdc25p
and Ras2-GTP, which was determined by ratios of Ras2-GTP/
Cdc25p. PKA mutants tagged with a 110 bp fragment containing
three HA-epitope repeats on the C-terminus of CDC25 were incu-bated on glucose medium and subjected to Cdc25p-Ras2-GTP/
RBD co-pull-down assay. Quantitative analysis (Fig. 4D) of western
blot (Fig. 4B and C) shows that the ratios of Ras2-GTP/Cdc25p are
increased in PKA-deleted mutants (DJ402 and DJ424), whereas
they are decreased in PKA-activated mutants (DJ304 and DJ301),
revealing that the intracellular association between Cdc25p and
Ras2-GTP is down-regulated by PKA. In mutant ZHS804 that
expressing ras2val19 allele, though the extremely high level of
Ras2-GTP (the sixth lane of Fig. 4B), the Cdc25p bound to
Ras2-GTP is not accordingly increased compared with DJ304 and
DJ301 (the sixth lane of Fig. 4C). This is consistent with the low
GTPase of Ras2val19 suppressing the Cdc25p requirement for activa-
tion of adenylate cyclase [25]. If the reduced association between
Cdc25p and Ras2-GTP was impaired due to the protein conforma-
tional change caused by the remarkable Cdc25p phosphorylation
modiﬁcation in PKA-activated mutants [22], Ras2-GTP should be
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Fig. 4E, we observed indistinguishable bands of Cdc25p associated
with either total Ras2p or Ras2-GTP, thus excluding the possible ef-
fect of Cdc25p phosphorylation modiﬁcation in regulating the
intracellular protein association between Cdc25p and Ras2-GTP.Fig. 4. Effect of PKA activity on the intracellular protein association between
Cdc25p and Ras2-GTP. PKA mutant cells were incubated on glucose medium to log
phase and Cdc25p–Ras2-GTP/RBD co-pull-down assay. (A) Immunoblots of total
Ras2p in cell lysate. (B) Immunoblots of Ras2-GTP bound to GST-RBD. (C)
Immunoblots of Cdc25p bound to Ras2-GTP. Protein samples were separated on
12.5% PAGE–SDS gels in the above immunoblots. (D) Ratios of Ras2-GTP/Cdc25p.
The ratio in wild-type cells (DJ401) was supposed to be a basic value that equals 1,
the rest of the values was determined by densitometric analysis and revised
according to the basic value. (E) The phosphorylation state of Cdc25p bound to total
Ras2p (left) or Ras2-GTP (right) in PKA mutants. Protein samples were separated
distinctly on a 6% PAGE–SDS gel.
Fig. 5. Effect of protein kinase treatment on the in vitro steady state of Cdc25p–
Ras2p and Cdc25p–Ras2-GTP complexes. Protein samples were separated on 12.5%
PAGE–SDS gels. Quantitative analysis of the in vitro steady state of Cdc25p–Ras2p
and Cdc25p–Ras2-GTP complexes was determined by the ratios of Ras2p/Cdc25p
(left) and Ras2-GTP/Cdc25p (right). The ratios of mock treated samples were
supposed to be a basic value that equals 1, the ratios of protein kinase treated
samples were determined by densitometric analysis and revised according to the
basic value.3.5. In vitro protein phosphorylation modiﬁcation by PKA does not
impair the steady state of Cdc25p-Ras2-GTP complexes
To further study the possible effect of protein phosphorylation
modiﬁcation on the stability of Cdc25p–Ras2-GTP complex in the
in vitro situation, the in vitro protein kinase assay was performed
on Cdc25p–Ras2p and Cdc25p–Ras2-GTP complexes. Both protein
complexes were obtained from cAPK-deleted cells (DJ424) due to
its low phosphorylation degree of Cdc25p [22]. Tpk1p was used
as the protein kinase due to the fact that it is sufﬁcient to remark-
ably phosphorylate Cdc25p in vivo [22]. Total Ras2p together with
its associated Cdc25p were immunoprecipitated using anti-Ras2
antibody to obtain the Cdc25p–Ras2p complex, and Ras2-GTP to-
gether with its bound Cdc25p were pull-down to obtain the
Cdc25p–Ras2-GTP complex. The kinase treated protein complexes
together with their mock treated samples were subjected to wes-
tern blot analysis. As quantitative analysis in Fig. 5, no signiﬁcant
reduction was obtained in the protein association after protein ki-
nase treatment, thus implicating that protein phosphorylation
modiﬁcation does not impair the steady state of both Cdc25p–
Ras2p and Cdc25p–Ras2-GTP complexes in the in vitro situation.
4. Discussion
Our study revealed a PKA-regulated intracellular localization of
Ras2p (Figs. 1 and 3), which is not inﬂuenced by the protein activa-
tion state (Fig. 3). The indistinguishable membrane localization of
both wild-type Ras2p and over active Ras2val19 protein in PKA-de-
leted mutant (Fig. 3) reveals the independence of Ras2p localiza-
tion on the protein activity, therefore excluding the possibility
that the GTP binding state of Ras2p may alter the protein confor-
mation, therefore leading to its intracellular relocalization.
It is known that Ras2-GEF Cdc25p is hyperphosphorylated and
relocalized from membrane to cytoplasm upon glucose signals
[21], and that the intracellular association of Cdc25p and Ras2p
was independent of PKA activity and consequently the PKA-regu-
lated Cdc25p phosphorylation [22]. The observed result of PKA-in-
duced Ras2p relocalization from membrane to the cytoplasm gave
further evidence proving a persistent protein association between
Ras2p and its positive regulator Cdc25p, therefore excluding the
possibility that Cdc25p is down-regulated by PKA through reduc-
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preferred phosphorylation site on Ras2p was serine 214 residue,
which can lead to promiscuous phosphorylation of Ras2p protein
and enhanced PKA activity when mutated to alanine [17,27]. We
examined the localization of Ras2ala214 protein and obtained no
signiﬁcant results revealing the relevance of Ras2p phosphoryla-
tion and localization except for some slight distinctions of mem-
brane localization due to the enhanced PKA (data not shown). On
the other hand, as Cyr1p activation is dependent upon the plasma
membrane localization of Ras2p, one might hypothesize that this
PKA-regulated relocalization of Ras2p may reduce its Cyr1p activa-
tion, therefore down-regulating cAMP signaling on the level of its
synthesis. However, this hypothesis needs further veriﬁcation.
Consistent with the elevated basal and induced Ras2-GTP level
in PKA-attenuated cells [18], our study further showed that the
Ras2-GTP binding capacity is tightly down-regulated by PKA (Figs.
2 and 4). Notably, the in vitro Ras2-GEF activity of puriﬁed Cdc25p
has been proved to be inhibited due to Cdc25p phosphorylation
modiﬁcation [22]. This led us to expect that the Ras2-GEF Cdc25p
might be involved the down-regulation of Ras2p by PKA through
some unknown mechanism. Cdc25p has been reported in a signif-
icant portion interacts with the GDP-bound form of Ras proteins,
catalyzing nucleotide exchange to produce GTP-bound of Ras pro-
teins [28]. Cdc25p cycles between Cdc25p–Ras2-GDP and Cdc25p–
Ras2-GTP binding states: as the Cdc25p-catalyzed nucleotide ex-
change reactions on Ras2p proceed, the interaction between
Cdc25p and Ras2-GTP is terminated, then Cdc25p is free from
Cdc25p–Ras2-GTP complex and continue to interact with another
Ras2-GDP [29]. Therefore the intracellular protein association in-
side the Cdc25p–Ras2-GTP complex is the critical issue to uncover
the role of Cdc25p in the down-regulation of Ras2p activity.
As the remarkable PKA-regulated Cdc25p phosphorylation
[21,22], one might hypothesize that the Cdc25p–Ras2-GTP com-
plex stability might be in a great extent dependent on the prefera-
ble association of protein in a certain conformation, which was
effected by the remarkable Cdc25p phosphorylation modiﬁcation.
This possibility was excluded in both in vivo and in vitro situations
(Figs. 4E and 5). Moreover, Ras2ala214 protein exhibits no signiﬁcant
distinction in association with Cdc25p or association between
Ras2-GTP and Cdc25p compared with wild-type Ras2p under our
experimental conditions (data not shown), implicating the inde-
pendence of Ras2p phosphorylation on the stability of Cdc25p–
Ras2p and Cdc25p–Ras2-GTP complexes. Fig. 4D showed a down-
regulation of Ras2-GTP/Cdc25p ratios by PKA, thus implicating that
the level of Ras2-GTP activated by equal amount of Cdc25p was re-
duced when PKA is activated. This result is also consistent with the
reduced Ras2-GEF activity of hyperphosphorylated Cdc25p [22].
Therefore the down-regulation of Ras2-GTP/Cdc25p ratios by PKA
can be ascribed to the negative regulation of Ras2-GEF Cdc25p
activity by PKA, suggesting that the Ras2-GEF Cdc25p activity play
a role in the feedback regulation of Ras2p by PKA.
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